Zarna - AI Associates for Private Equity

What

Zarna is an AI associate platform built for private equity deal teams. It captures deal data from sources such as emails, CIMs, CRM records, meetings, attachments, and VDR-related materials, structures and cleans that data, and then uses role-based agents to generate work products and deliver them into tools teams already use, including Outlook, Teams, and Slack.

The product is positioned as an embedded, workflow-level system rather than a chatbot or a generic automation builder. Its core value is turning fragmented deal information into a queryable institutional memory and using that foundation to automate screening, memo drafting, CRM logging, network mapping, and proactive deal analysis without requiring users to work primarily inside a separate application.

Features

• Automated data capture and structuring: Ingests emails, documents, meeting notes, CRM data, and attachments so firms can centralize deal information from day one.
• Data cleaning and institutional memory: Applies deduplication, folder taxonomy, and record resolution to create a more reliable, queryable history of deals, contacts, and interactions.
• Scribe agent for logging and filing: Captures and logs deal information across firm tools, files documents consistently, and helps reduce manual CRM and knowledge-management work.
• Memo agent for document generation: Produces screening memos, banker call briefs, summaries, reports, and formatted outputs based on structured deal data and firm templates.
• Analyst agent for mandate scoring: Scores inbound teasers and CIMs against firm mandate and historical records to surface analogs, risks, and opportunities earlier in the process.
• Experts agent for network intelligence: Maps warm introductions, operating partners, portfolio connections, and contact timelines to support sourcing and diligence workflows; the page labels this capability as beta.

Helpful Tips

• Assess data readiness first: Products in this category depend heavily on email, CRM, notes, and document quality, so review naming standards, field consistency, and document organization before rollout.
• Start with a narrow workflow: Screening memos, banker call prep, or CRM logging are practical entry points because they are repetitive, measurable, and easier to validate for accuracy.
• Define approval and exception rules: Zarna mentions configurable approval gates and field mappings, which are important for controlling where autonomous outputs can be trusted versus reviewed.
• Validate historical matching carefully: Any mandate-fit scoring or historical analog surfacing should be tested against real firm decisions to make sure recommendations reflect actual investment logic rather than noisy records.
• Use pilot metrics critically: The site emphasizes ROI tracking, but buyers should confirm how hours saved, output quality, and accuracy are calculated and how much internal oversight is still required.

OpenClaw Skills

Zarna could fit well into an OpenClaw ecosystem as a source-and-action layer for private equity workflows. Likely OpenClaw skills could monitor incoming CIMs, classify opportunities by sector or mandate, route banker materials to the right internal owners, summarize new developments across portfolio or pipeline activity, and trigger downstream diligence workflows based on what Zarna captures and scores. If OpenClaw has orchestration and agent-governance capabilities, it could extend Zarna’s delivered outputs into broader multi-step operating routines.

A likely high-value use case would be combining Zarna’s private-equity-specific data capture and memo generation with OpenClaw agents for investment committee preparation, portfolio monitoring, expert outreach sequencing, or post-meeting follow-up. This is an inferred workflow, not a confirmed native integration from the page. In practice, that combination could move deal teams toward a more continuous operating model where data capture, triage, analysis, and communication happen as an ongoing system rather than as manual associate-driven batches.